Shintaro Ishikawa
Impact in
- Clinical Biochemistry top 1%
- Advanced Glycation End Products research
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
Papers in
- Oncology 15
- Colorectal Cancer Surgical Treatments 6
-
- Angiogenesis and VEGF in Cancer 4
- Co-authors
- Zenji Makita (2 shared papers)KOICHI YASUMURA (2 shared papers)Tadashi Hisamitsu (23 shared papers)Katsuyuki Yanagisawa (1 shared paper)Takao Koike (1 shared paper)Tetsuya Kawata (1 shared paper)Masataka Sunagawa (15 shared papers)Sakurako Nakamura (1 shared paper)
In The Last Decade
Shintaro Ishikawa
54 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 98
- Clinical Biochemistry 309
- Nephrology 156
- Aging 22
- Endocrinology, Diabetes and Metabolism 177
- Neurology 83
Countries citing papers authored by Shintaro Ishikawa
This map shows the geographic impact of Shintaro Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shintaro Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shintaro Ishikawa more than expected).
Fields of papers citing papers by Shintaro Ishikawa
This network shows the impact of papers produced by Shintaro Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shintaro Ishikawa. The network helps show where Shintaro Ishikawa may publish in the future.
Co-authors
The 25 scholars most cited alongside Shintaro Ishikawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 184 | |
| 2 | 1999 | 179 | |
| 3 | Beta/A4 proteinlike immunoreactive granular structures in the brain of senescence-accelerated mouse. | 1993 | 87 |
| 4 | 1999 | 72 | |
| 5 | 2016 | 45 | |
| 6 | 2013 | 39 | |
| 7 | 2004 | 37 | |
| 8 | 2001 | 37 | |
| 9 | 2017 | 27 | |
| 10 | 2017 | 23 | |
| 11 | 2017 | 23 | |
| 12 | 2019 | 22 | |
| 13 | 2016 | 18 | |
| 14 | 2017 | 18 | |
| 15 | 1993 | 17 | |
| 16 | 2020 | 17 | |
| 17 | 2011 | 16 | |
| 18 | 2022 | 15 | |
| 19 | Influence of Palmatine on Bone Metabolism in Ovariectomized Mice and Cytokine Secretion of Osteoblasts. | 2016 | 15 |
| 20 | 2011 | 14 |
About Shintaro Ishikawa
Shintaro Ishikawa is a scholar working on Oncology, Molecular Biology, Surgery, Pulmonary and Respiratory Medicine and Complementary and alternative medicine, having authored 60 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acupuncture Treatment Research Studies (6 papers), Colorectal Cancer Surgical Treatments (6 papers), Gastrointestinal Tumor Research and Treatment (5 papers), Gastric Cancer Management and Outcomes (5 papers), Angiogenesis and VEGF in Cancer (4 papers), Healthcare and Venom Research (4 papers), Heart Rate Variability and Autonomic Control (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Clinical Biochemistry (309 citations), Nephrology (156 citations), Aging (22 citations), Endocrinology, Diabetes and Metabolism (177 citations) and Neurology (83 citations). Shintaro Ishikawa has collaborated with scholars based in Japan, China and Indonesia. Frequent co-authors include Zenji Makita, KOICHI YASUMURA, Tadashi Hisamitsu, Katsuyuki Yanagisawa, Takao Koike, Tetsuya Kawata, Masataka Sunagawa, Sakurako Nakamura, Takayoshi Koike and Tatsuya Atsumi. Their work appears in journals such as Journal of Acupuncture and Meridian Studies, Evidence-based Complementary and Alternative Medicine, Oncotarget, The American Surgeon and Advanced Robotics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.